Skip to content

Management of Postpartum Preeclampsia

Management of Postpartum Preeclampsia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05775744
Acronym
MOPP
Enrollment
392
Registered
2023-03-20
Start date
2023-03-28
Completion date
2024-03-26
Last updated
2024-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Preeclampsia

Brief summary

The aim of this study is to assess the effect of a lower treatment threshold for antihypertensive medication and tighter blood pressure control, using remote blood pressure monitoring, on reducing Emergency Room visits for our postpartum patients with hypertensive disease.

Detailed description

The aim of this study is to assess the effect of lower treatment threshold for initiating antihypertensive medication and tighter blood pressure control, using remote blood pressure monitoring, on reducing Emergency Room visits for our postpartum patients with hypertensive disease. The investigators will study and compare two cohorts of patients. The first is a retrospective cohort, including patients delivered at Robert Wood Johnson University Hospital and Cooperman Barnabas Medical Center. The second is a prospective cohort that will enroll patients immediately postpartum who are eligible for our treatment protocol.

Interventions

OTHERTight postpartum blood pressure control

The standard of care for patients with pregnancy induced hypertension is to start antihypertensive therapy if blood pressures are consistently over 150/100 mm Hg. There is no established standard of care for titrating blood pressure medication in the postpartum period for those with chronic hypertension and the approach to these patients varies by institution. The intervention in this study will be to start antihypertensive medications at a lower blood pressure cutoff, which is commonly used in the non-pregnant patient population to more tightly control blood pressure. Remote patient monitoring may be considered standard of care. The blood pressure targets chosen for this study are considered to be standard of care for non-pregnant people.

Sponsors

Rutgers, The State University of New Jersey
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The investigators will study and compare two cohorts of patients. The first is a retrospective cohort, including patients delivered at Robert Wood Johnson University Hospital and Cooperman Barnabas Medical Center. The second is a prospective cohort that will enroll patients immediately postpartum who are eligible for our treatment protocol.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Chronic hypertension, gestational hypertension, or preeclampsia. * Delivery of a neonate after 20 weeks during their current hospitalization * Able to consent * 18 years old or above * English or Spanish speaking * Planning to follow up with a physician associated with Robert Wood Johnson University Hospital or Cooperman Barnabas Medical Center * Ability to follow directions

Exclusion criteria

* Any medical condition that the providers feel is a contraindication to the MOPP algorithm. * Planning to follow up with an outside institution. * Unwillingness to take blood pressure at home.

Design outcomes

Primary

MeasureTime frameDescription
Postpartum Emergency Department visits for hypertensive disordersSix weeks from date of deliveryAny patient that returns to the Emergency Department for hypertensive disorders

Secondary

MeasureTime frameDescription
Number of acute postpartum complications of preeclampsia6 weeks from date of deliveryPostpartum complications include stroke, seizure, thrombocytopenia, elevated liver enzymes, liver rupture, kidney injury.
Lab abnormalities because of preeclampsia6 weeks from date of deliveryRate of lab abnormalities including acute kidney injury (creatinine \>1.1 mg/dL), transaminitis (liver function tests \> 2x upper limit of normal), or thrombocytopenia (platelet count \< 100,000 uL)
Blood pressure at the postpartum visit6 weeks from date of deliveryMeasurement of blood pressure value at 6 week postpartum visit
Breastfeeding rates at 6 weeks postpartum6 weeks from date of deliveryRates of exclusive breastfeeding at 6 week postpartum visit.
Postpartum readmissions for hypertensive disorders6 weeks form date of deliveryAny patient that is readmitted to the hospital for hypertensive disorders.
Composite maternal cardiovascular and other morbidityOne year from deliveryDeath, any new heart failure, stroke or encephalopathy, myocardial ischemia or angina, pulmonary edema, ICU admission/ intubation, encephalopathy, or renal failure.
Short-term cardiovascular diseaseOne year from deliveryThe effect of aggressive postpartum preeclampsia on incidents of cardiovascular diseases, which include coronary heart disease (acute myocardial infarction, ischemic heart disease, hypertensive heart disease, and congestive heart failure), and stroke (ischemic and hemorrhagic strokes).
Socioeconomic factorsOne year from deliveryThe impact of race/ethnicity and insurance status on primary and secondary outcomes.
Compliance with follow up at postpartum visits6 weeks from date of deliveryIf patient shows up to postpartum visit or not

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026